Erasca
anticipated key milestones and clinical trial | Erasca
Company
Deck Type
Sector
Industry
Deck date
January 2024
Slide
34 of 41
Similar slides by Erasca
See diffirences between slides (animation)
Investor Presentation
November 2023
anticipated key milestones and clinical trial | Erasca
Investor Presentation
August 2023
anticipated key milestones and clinical trial | Erasca
Related slides by other companies
ATAI
Investor Presentation
March 2023
phase proof of concept trial design all subjects tid tid placebo trial status in data anticipated randomized week study of and patients with | ATAI
Genelux
Investor Presentation
December 2023
phase anti tumor activity as leading into combination a | Genelux
Compass Therapeutics
Investor Presentation
May 2023
phase combination study | Compass Therapeutics
RayzeBio
IPO
September 2023
phase trial in first line combination treatment of | RayzeBio
Other recent decks by Erasca
See all presentations (4 decks)
Investor Presentation
November 2023
Investor Presentation
August 2023
IPO
July 2021
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights